Who owns Quinlan Paul T?

No ownership or control links for Quinlan Paul T are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.

What is Quinlan Paul T's risk level?

WhiteIntel flags Quinlan Paul T as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.

Where does Quinlan Paul T appear across sources?

Quinlan Paul T is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

LIVE · CORPUS

PersonLow

Quinlan Paul T

Name: Quinlan Paul T — ownership dossier
Creator: WhiteIntel
License: https://whiteintel.dev/terms
Keywords: corporate ownership, beneficial ownership, UBO, corporate intelligence, OSINT, corporate registry, Quinlan Paul T, Person, US

Quinlan Paul T — US person (sec:0001333277). 4 holdings. Every claim linked to its source.

controls 4 companies

Ownership graph Export .md

JSON / MCPsample

The finding

Controls or directs 4 companies in the resolved graph.

Investigative lead by resolved identity, not a legal determination.

/01

Registry identity

Controls: 4 companies
Risk: Low
Jurisdiction: US

/02

Control & directorships

Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.

Controlled by

None in current sources.

Directorships & controlled companies

Quinlan Paul T
- Oruka Therapeutics, Inc.· officer· via SEC EDGAR (Form 3/4/5)
- CYMABAY THERAPEUTICS, INC.· officer· via SEC EDGAR
- SOLAZYME INC· officer· via SEC EDGAR

Nothing further is withheld here. The ownership and control links above are everything we have resolved for Quinlan Paul T — there is no deeper chain behind a paywall. Absence means “not observed in our current sources” — it is not a finding of none.

Monitoring

Coverage of Quinlan Paul T is still thin in the current sources. Watch it and we'll flag the moment new ownership, filings or risk signals land.

Explore US coverage

WHAT YOU CAN SEEFREE

YOURS NOW · FREE

4 items you can read right now — no account, no payment.

Identity, nationality & aliases
Sanctions, PEP & watchlist detail
Direct connections (1 hop)
Community notes

Nothing further on Quinlan Paul T is behind a paywall — everything we hold on this subject is already on this page.

/03

People & control

3 parties · 0 current

Every officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.

●
CYMABAY THERAPEUTICS, INC.
Also holds roles at 38 other companies
- LOEWY CAROLINE Mdirector
- Shantharam Harishofficer
- EMSTER KURT VONdirector
●
Oruka Therapeutics, Inc.
Also holds roles at 115 other companies
- VHCP Management III, LLC10% owner
- Venrock Healthcare Capital Partners III, L.P.10% owner
- VHCP Management EG, LLC10% owner
●
SOLAZYME INC
Also holds roles at 33 other companies
- PFEIFFER GARY Mdirector
- CRAIGIE JAMESdirector
- ARBIGE MICHAEL Vdirector

3 parties · 0 current. Ceased and resigned records are retained as history.

/04

Common questions

Who owns Quinlan Paul T?: No ownership or control links for Quinlan Paul T are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.
What is Quinlan Paul T's risk level?: WhiteIntel flags Quinlan Paul T as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.
Where does Quinlan Paul T appear across sources?: Quinlan Paul T is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

Community intel

Crowd leads · unverified

Tips, corrections and leads contributed by the community on Quinlan Paul T. These are unverified leads, not WhiteIntel findings — we surface them for investigators to chase, and analyse the corroborated ones into SnitchScore.

Loading tips…